These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30056039)

  • 1. Predictors of clinically meaningful change in PDQ-39 in Parkinson's disease.
    Margolius A; Cubillos F; He Y; Wu S; Schmidt P; Simuni T;
    Parkinsonism Relat Disord; 2018 Nov; 56():93-97. PubMed ID: 30056039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caregiver strain in Parkinson's disease: national Parkinson Foundation Quality Initiative study.
    Oguh O; Kwasny M; Carter J; Stell B; Simuni T
    Parkinsonism Relat Disord; 2013 Nov; 19(11):975-9. PubMed ID: 23871587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regular Exercise, Quality of Life, and Mobility in Parkinson's Disease: A Longitudinal Analysis of National Parkinson Foundation Quality Improvement Initiative Data.
    Rafferty MR; Schmidt PN; Luo ST; Li K; Marras C; Davis TL; Guttman M; Cubillos F; Simuni T;
    J Parkinsons Dis; 2017; 7(1):193-202. PubMed ID: 27858719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Back to the basics: regular exercise matters in parkinson's disease: results from the National Parkinson Foundation QII registry study.
    Oguh O; Eisenstein A; Kwasny M; Simuni T
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1221-5. PubMed ID: 25258329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobility, mood and site of care impact health related quality of life in Parkinson's disease.
    Nutt JG; Siderowf AD; Guttman M; Schmidt PN; Zamudio JI; Wu SS; Okun MS; Simuni T; Parashos SA; Dahodwala NA; Davis TL; Giladi N; Gurevich T; Hauser RA; Jankovic J; Lyons KE; Marsh L; Miyasaki JM; Morgan JC; Santiago AJ; Tarsy D; Mari Z; Malaty IA; Nelson EC;
    Parkinsonism Relat Disord; 2014 Mar; 20(3):274-9. PubMed ID: 24182524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Profile of Long-term Parkinson's Disease Survivors with 20 Years of Disease Duration and Beyond.
    Hassan A; Wu SS; Schmidt P; Simuni T; Giladi N; Miyasaki JM; Bloem BR; Malaty IA; Okun MS
    J Parkinsons Dis; 2015; 5(2):313-9. PubMed ID: 25720446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What are the issues facing Parkinson's disease patients at ten years of disease and beyond? Data from the NPF-QII study.
    Hassan A; Wu SS; Schmidt P; Malaty IA; Dai YF; Miyasaki JM; Okun MS
    Parkinsonism Relat Disord; 2012 Dec; 18 Suppl 3():S10-4. PubMed ID: 22776044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between objectively measured physical activity, depression, cognition, and health-related quality of life in Parkinson's disease.
    van Uem JMT; Cerff B; Kampmeyer M; Prinzen J; Zuidema M; Hobert MA; Gräber S; Berg D; Maetzler W; Liepelt-Scarfone I
    Parkinsonism Relat Disord; 2018 Mar; 48():74-81. PubMed ID: 29307560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and Parkinson's disease: Philippine translation and validation of the Parkinson's disease questionnaire.
    Suratos CTR; Saranza GRM; Sumalapao DEP; Jamora RDG
    J Clin Neurosci; 2018 Aug; 54():156-160. PubMed ID: 29907384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight loss and impact on quality of life in Parkinson's disease.
    Akbar U; He Y; Dai Y; Hack N; Malaty I; McFarland NR; Hess C; Schmidt P; Wu S; Okun MS
    PLoS One; 2015; 10(5):e0124541. PubMed ID: 25938478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Quality of Life in Parkinson's Disease: How Large Must They Be to Be Relevant?
    Horváth K; Aschermann Z; Kovács M; Makkos A; Harmat M; Janszky J; Komoly S; Karádi K; Kovács N
    Neuroepidemiology; 2017; 48(1-2):1-8. PubMed ID: 28161701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease.
    Dafsari HS; Weiß L; Silverdale M; Rizos A; Reddy P; Ashkan K; Evans J; Reker P; Petry-Schmelzer JN; Samuel M; Visser-Vandewalle V; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Brain Stimul; 2018; 11(4):867-874. PubMed ID: 29655587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-centered integrated healthcare improves quality of life in Parkinson's disease patients: a randomized controlled trial.
    Eggers C; Dano R; Schill J; Fink GR; Hellmich M; Timmermann L;
    J Neurol; 2018 Apr; 265(4):764-773. PubMed ID: 29392459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
    Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of fatigue on health-related quality of life in patients with Parkinson's disease.
    Herlofson K; Larsen JP
    Acta Neurol Scand; 2003 Jan; 107(1):1-6. PubMed ID: 12542506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of quality of life in people with Parkinson's disease: evidence for both domain specific and general relationships.
    Simpson J; Lekwuwa G; Crawford T
    Disabil Rehabil; 2014; 36(23):1964-70. PubMed ID: 24499208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life implications for elevated trait impulsivity in people with Parkinson's disease.
    Jeyadevan A; Bakeberg M; Byrnes M; Kenna J; McGregor S; Ghosh S; Horne MK; Stell R; Evans T; Mastaglia FL; Anderton R
    Qual Life Res; 2023 Apr; 32(4):1143-1150. PubMed ID: 36637657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Key Determinants to Quality of Life in Parkinson's Disease Patients: Results from the Parkinson's Disease Biomarker Program (PDBP).
    He L; Lee EY; Sterling NW; Kong L; Lewis MM; Du G; Eslinger PJ; Huang X
    J Parkinsons Dis; 2016 May; 6(3):523-32. PubMed ID: 27258700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease.
    Dafsari HS; Ray-Chaudhuri K; Mahlstedt P; Sachse L; Steffen JK; Petry-Schmelzer JN; Dembek TA; Reker P; Barbe MT; Visser-Vandewalle V; Fink GR; Timmermann L
    Eur J Neurol; 2019 Feb; 26(2):222-e17. PubMed ID: 30107062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.